Aytu BioPharma, Inc. (AYTU)

Aytu BioPharma Cash Flow Statement

Financials in millions USD. Fiscal year is July - June.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec 31, 2025	Jun 30, 2025	Jun 30, 2024	Jun 30, 2023	Jun 30, 2022	Jun 30, 2021
Net Income	-24.44	-13.56	-15.84	-17.05	-108.78	-58.29
Depreciation & Amortization	4.44	5.38	6.73	7.7	10.15	9.2
Other Amortization	0.11	0.11	0.6	0.56	-	-
Asset Writedown & Restructuring Costs	8.26	8.26	-	2.73	75.46	12.83
Stock-Based Compensation	0.65	0.58	2.37	5.72	5.25	3.57
Provision & Write-off of Bad Debts	-	-	-	-	-	0.61
Other Operating Activities	14.54	2.78	6.06	-5.17	-0.03	4.44
Change in Accounts Receivable	-5.6	-7.63	5.2	-7.24	6.53	1.54
Change in Inventory	1.09	0.38	-4.82	-3.49	1.3	2.79
Change in Accounts Payable	-0.38	0.29	-2.08	3.09	-7.68	-3.25
Change in Other Net Operating Assets	0.4	0.96	-5.03	2.65	-11.01	0.6
Operating Cash Flow	-0.6	-1.94	-1.39	-5.13	-28.82	-25.96
Capital Expenditures	-0.1	-0.23	-0.33	-	-	-2.34
Sale of Property, Plant & Equipment	-	0.67	-	-	-	-
Cash Acquisitions	-	-	-	-	-3.18	-0.48
Sale (Purchase) of Intangibles	-3	-3	-	-	-	-
Other Investing Activities	-	-	-	-0.12	-0.07	0.04
Investing Cash Flow	-3.1	-2.56	-0.33	-0.12	-3.25	-2.78
Short-Term Debt Issued	-	6.67	0.83	-	-	51.21
Long-Term Debt Issued	-	1.86	13	-	15	-
Total Debt Issued	6.92	8.53	13.83	-	15	51.21
Short-Term Debt Repaid	-	-	-	-2.25	-4.12	-53.98
Long-Term Debt Repaid	-	-1.86	-15.72	-0.1	-16.1	-0.97
Total Debt Repaid	-1.86	-1.86	-15.72	-2.35	-20.22	-54.95
Net Debt Issued (Repaid)	5.06	6.67	-1.89	-2.35	-5.22	-3.74
Issuance of Common Stock	14.84	14.84	3.47	15.58	11.69	40.15
Other Financing Activities	-6.58	-6.07	-2.84	-4.36	-4.94	-6.09
Financing Cash Flow	13.33	15.44	-1.26	8.87	1.53	30.31
Net Cash Flow	9.63	10.95	-2.98	3.63	-30.54	1.57
Free Cash Flow	-0.7	-2.17	-1.72	-5.13	-28.82	-28.31
Free Cash Flow Margin	-1.11%	-3.26%	-2.63%	-6.95%	-29.82%	-43.13%
Free Cash Flow Per Share	-0.09	-0.34	-0.31	-1.54	-19.61	-33.80
Cash Interest Paid	3.03	2.82	4.04	3.81	3.15	1.25
Cash Income Tax Paid	0.2	1.42	1.61	-	-	-
Levered Free Cash Flow	-6.98	-9.49	3.92	5.56	-17.72	15.64
Unlevered Free Cash Flow	-5.4	-7.29	6.49	8.22	-17.71	15.64
Change in Working Capital	-4.5	-6	-6.73	-4.99	-10.86	1.68

Updated Feb 3, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q